Concepts (211)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chagas Disease | 15 | 2024 | 294 | 4.120 |
Why?
|
| Trypanosoma cruzi | 13 | 2024 | 236 | 3.760 |
Why?
|
| Insect Vectors | 10 | 2024 | 109 | 2.400 |
Why?
|
| Triatoma | 6 | 2024 | 29 | 2.130 |
Why?
|
| Mosquito Vectors | 3 | 2025 | 35 | 1.910 |
Why?
|
| Texas | 21 | 2025 | 3584 | 1.350 |
Why?
|
| Culex | 2 | 2025 | 33 | 1.170 |
Why?
|
| Spotted Fever Group Rickettsiosis | 2 | 2025 | 5 | 1.120 |
Why?
|
| Rickettsia | 2 | 2025 | 13 | 1.110 |
Why?
|
| Superantigens | 2 | 2017 | 20 | 1.060 |
Why?
|
| Immunoglobulin M | 5 | 2024 | 212 | 1.050 |
Why?
|
| Spatial Analysis | 2 | 2024 | 21 | 0.980 |
Why?
|
| Rickettsia Infections | 1 | 2025 | 7 | 0.960 |
Why?
|
| Arboviruses | 1 | 2025 | 27 | 0.950 |
Why?
|
| Protozoan Infections | 1 | 2025 | 15 | 0.950 |
Why?
|
| Arbovirus Infections | 1 | 2025 | 31 | 0.940 |
Why?
|
| Cysticercosis | 1 | 2024 | 22 | 0.930 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 2025 | 40 | 0.920 |
Why?
|
| Culicidae | 1 | 2025 | 67 | 0.920 |
Why?
|
| Neurocysticercosis | 1 | 2024 | 27 | 0.920 |
Why?
|
| Helminthiasis | 1 | 2025 | 77 | 0.880 |
Why?
|
| Antibodies, Catalytic | 2 | 2018 | 7 | 0.850 |
Why?
|
| Mexican Americans | 1 | 2024 | 204 | 0.840 |
Why?
|
| Ehrlichiosis | 1 | 2021 | 10 | 0.750 |
Why?
|
| Antibodies, Protozoan | 2 | 2018 | 76 | 0.730 |
Why?
|
| Animals | 27 | 2025 | 34088 | 0.620 |
Why?
|
| Disease Reservoirs | 1 | 2018 | 35 | 0.600 |
Why?
|
| Deer | 1 | 2018 | 19 | 0.600 |
Why?
|
| Protozoan Proteins | 1 | 2018 | 111 | 0.560 |
Why?
|
| West Nile Fever | 4 | 2024 | 139 | 0.550 |
Why?
|
| Animals, Domestic | 1 | 2016 | 31 | 0.540 |
Why?
|
| Animals, Wild | 1 | 2016 | 26 | 0.540 |
Why?
|
| Cysteine | 1 | 2017 | 136 | 0.530 |
Why?
|
| Relapsing Fever | 3 | 2021 | 56 | 0.520 |
Why?
|
| Seroepidemiologic Studies | 3 | 2025 | 122 | 0.520 |
Why?
|
| Borrelia | 3 | 2021 | 68 | 0.520 |
Why?
|
| Antigens, Protozoan | 1 | 2015 | 66 | 0.490 |
Why?
|
| West Nile virus | 3 | 2022 | 117 | 0.460 |
Why?
|
| Aedes | 2 | 2025 | 100 | 0.440 |
Why?
|
| Occupational Exposure | 1 | 2015 | 127 | 0.440 |
Why?
|
| Dengue | 2 | 2024 | 113 | 0.390 |
Why?
|
| Dengue Virus | 2 | 2024 | 127 | 0.380 |
Why?
|
| Ornithodoros | 2 | 2021 | 40 | 0.360 |
Why?
|
| Humans | 34 | 2025 | 124618 | 0.350 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 841 | 0.310 |
Why?
|
| Young Adult | 5 | 2025 | 9014 | 0.310 |
Why?
|
| Middle Aged | 9 | 2025 | 26714 | 0.290 |
Why?
|
| Communicable Diseases | 2 | 2022 | 160 | 0.290 |
Why?
|
| Belize | 2 | 2024 | 14 | 0.270 |
Why?
|
| Cities | 2 | 2024 | 47 | 0.270 |
Why?
|
| Mexico | 2 | 2025 | 182 | 0.270 |
Why?
|
| Immunization | 2 | 2018 | 307 | 0.260 |
Why?
|
| Cross-Sectional Studies | 2 | 2025 | 3424 | 0.260 |
Why?
|
| Prevalence | 2 | 2025 | 2445 | 0.250 |
Why?
|
| Blastocystis | 1 | 2025 | 7 | 0.240 |
Why?
|
| Population Dynamics | 1 | 2025 | 31 | 0.240 |
Why?
|
| Female | 15 | 2025 | 66495 | 0.240 |
Why?
|
| Poverty Areas | 1 | 2025 | 33 | 0.240 |
Why?
|
| Phylogeny | 4 | 2022 | 695 | 0.240 |
Why?
|
| Population Density | 1 | 2024 | 34 | 0.240 |
Why?
|
| Strongyloides stercoralis | 1 | 2025 | 23 | 0.240 |
Why?
|
| B-Lymphocytes | 2 | 2018 | 533 | 0.240 |
Why?
|
| Adult | 10 | 2025 | 29440 | 0.240 |
Why?
|
| Taenia solium | 1 | 2024 | 11 | 0.240 |
Why?
|
| Male | 15 | 2025 | 61200 | 0.230 |
Why?
|
| Climate Change | 1 | 2025 | 42 | 0.230 |
Why?
|
| Antibodies, Helminth | 1 | 2024 | 125 | 0.230 |
Why?
|
| Prealbumin | 1 | 2014 | 27 | 0.220 |
Why?
|
| RNA, Viral | 2 | 2024 | 540 | 0.220 |
Why?
|
| Amyloid | 1 | 2014 | 65 | 0.220 |
Why?
|
| Cat Diseases | 1 | 2023 | 15 | 0.220 |
Why?
|
| Adolescent | 7 | 2025 | 19278 | 0.210 |
Why?
|
| Toxocariasis | 1 | 2023 | 27 | 0.210 |
Why?
|
| Seasons | 1 | 2025 | 310 | 0.210 |
Why?
|
| Dog Diseases | 1 | 2023 | 50 | 0.210 |
Why?
|
| Proteolysis | 1 | 2014 | 171 | 0.210 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2025 | 822 | 0.210 |
Why?
|
| Travel | 1 | 2024 | 116 | 0.210 |
Why?
|
| Antibodies, Bacterial | 1 | 2025 | 388 | 0.210 |
Why?
|
| Body Fluids | 2 | 2019 | 47 | 0.190 |
Why?
|
| Immunoglobulin G | 1 | 2025 | 777 | 0.190 |
Why?
|
| Risk Factors | 3 | 2025 | 10270 | 0.190 |
Why?
|
| Meningitis, Aseptic | 1 | 2021 | 12 | 0.190 |
Why?
|
| Tick Infestations | 1 | 2021 | 9 | 0.190 |
Why?
|
| Biodiversity | 1 | 2021 | 64 | 0.190 |
Why?
|
| Aged | 5 | 2025 | 19703 | 0.180 |
Why?
|
| Immunoglobulin A, Secretory | 1 | 2020 | 20 | 0.180 |
Why?
|
| Antibody Specificity | 2 | 2015 | 202 | 0.180 |
Why?
|
| Public Health | 2 | 2023 | 262 | 0.160 |
Why?
|
| Virus Diseases | 1 | 2022 | 280 | 0.160 |
Why?
|
| Residence Characteristics | 2 | 2021 | 277 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 2 | 2019 | 1586 | 0.150 |
Why?
|
| Antibody Formation | 1 | 2018 | 266 | 0.140 |
Why?
|
| Mice | 4 | 2022 | 17639 | 0.140 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 866 | 0.140 |
Why?
|
| DNA, Kinetoplast | 1 | 2017 | 3 | 0.140 |
Why?
|
| Hydrolysis | 1 | 2017 | 161 | 0.140 |
Why?
|
| Arachnid Vectors | 1 | 2017 | 10 | 0.140 |
Why?
|
| Carrier State | 1 | 2017 | 77 | 0.140 |
Why?
|
| Bacteria | 1 | 2020 | 484 | 0.130 |
Why?
|
| Incidence | 2 | 2021 | 3138 | 0.130 |
Why?
|
| Methicillin Resistance | 1 | 2017 | 118 | 0.130 |
Why?
|
| Chagas Cardiomyopathy | 1 | 2017 | 48 | 0.130 |
Why?
|
| Serine | 1 | 2017 | 173 | 0.130 |
Why?
|
| Cardiomyopathies | 1 | 2021 | 492 | 0.130 |
Why?
|
| Protozoan Vaccines | 1 | 2017 | 96 | 0.130 |
Why?
|
| Food Chain | 1 | 2016 | 10 | 0.130 |
Why?
|
| Family Health | 1 | 2017 | 258 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 1004 | 0.130 |
Why?
|
| Protein Isoforms | 1 | 2017 | 406 | 0.130 |
Why?
|
| Fever | 3 | 2023 | 294 | 0.130 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 325 | 0.130 |
Why?
|
| Sequence Alignment | 1 | 2017 | 622 | 0.120 |
Why?
|
| Genotype | 2 | 2019 | 2556 | 0.120 |
Why?
|
| Tuberculosis | 1 | 2020 | 521 | 0.110 |
Why?
|
| Immunity, Innate | 1 | 2017 | 375 | 0.110 |
Why?
|
| Military Personnel | 1 | 2017 | 212 | 0.110 |
Why?
|
| Disease Transmission, Infectious | 1 | 2015 | 84 | 0.110 |
Why?
|
| Staphylococcus aureus | 1 | 2017 | 458 | 0.110 |
Why?
|
| Pandemics | 1 | 2021 | 1099 | 0.100 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 700 | 0.100 |
Why?
|
| Vaccination | 1 | 2018 | 954 | 0.100 |
Why?
|
| Staphylococcal Infections | 1 | 2017 | 557 | 0.100 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 1390 | 0.100 |
Why?
|
| Ecosystem | 2 | 2024 | 77 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 1269 | 0.090 |
Why?
|
| Child | 5 | 2023 | 24374 | 0.090 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2021 | 369 | 0.080 |
Why?
|
| Saliva | 2 | 2020 | 114 | 0.080 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 6533 | 0.080 |
Why?
|
| Risk Assessment | 2 | 2016 | 3445 | 0.080 |
Why?
|
| HIV Infections | 1 | 2020 | 1893 | 0.080 |
Why?
|
| United States | 5 | 2023 | 10891 | 0.080 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3281 | 0.080 |
Why?
|
| Infant | 2 | 2020 | 12468 | 0.070 |
Why?
|
| Child, Preschool | 2 | 2020 | 14009 | 0.070 |
Why?
|
| Epidemiological Monitoring | 2 | 2018 | 59 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 2521 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2015 | 3694 | 0.060 |
Why?
|
| Weather | 1 | 2024 | 11 | 0.060 |
Why?
|
| Florida | 1 | 2024 | 78 | 0.060 |
Why?
|
| Nicaragua | 1 | 2024 | 26 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 2 | 2021 | 1758 | 0.060 |
Why?
|
| Serogroup | 1 | 2024 | 59 | 0.050 |
Why?
|
| Mutation | 1 | 2017 | 5826 | 0.050 |
Why?
|
| Zoonoses | 1 | 2023 | 44 | 0.050 |
Why?
|
| Cats | 1 | 2023 | 118 | 0.050 |
Why?
|
| Dominican Republic | 1 | 2023 | 16 | 0.050 |
Why?
|
| Feeding Behavior | 2 | 2021 | 711 | 0.050 |
Why?
|
| Substance P | 1 | 2022 | 34 | 0.050 |
Why?
|
| Dogs | 1 | 2023 | 768 | 0.050 |
Why?
|
| Panama | 1 | 2021 | 12 | 0.050 |
Why?
|
| Multilocus Sequence Typing | 1 | 2021 | 56 | 0.050 |
Why?
|
| Tick-Borne Diseases | 1 | 2021 | 10 | 0.050 |
Why?
|
| Ticks | 1 | 2021 | 30 | 0.050 |
Why?
|
| Rodentia | 1 | 2021 | 44 | 0.050 |
Why?
|
| Classification | 1 | 2020 | 18 | 0.040 |
Why?
|
| Discriminant Analysis | 1 | 2020 | 26 | 0.040 |
Why?
|
| Haplotypes | 1 | 2022 | 521 | 0.040 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2023 | 190 | 0.040 |
Why?
|
| Philippines | 1 | 2020 | 23 | 0.040 |
Why?
|
| Plasmids | 1 | 2021 | 510 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2021 | 478 | 0.040 |
Why?
|
| Dysbiosis | 1 | 2020 | 122 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2023 | 468 | 0.040 |
Why?
|
| Vero Cells | 1 | 2019 | 110 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2020 | 245 | 0.040 |
Why?
|
| Semen | 1 | 2019 | 72 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2019 | 4795 | 0.040 |
Why?
|
| Hospitals, Pediatric | 1 | 2023 | 770 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2022 | 1388 | 0.040 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2018 | 63 | 0.040 |
Why?
|
| Family Characteristics | 2 | 2017 | 72 | 0.040 |
Why?
|
| Triatominae | 1 | 2017 | 4 | 0.040 |
Why?
|
| Arizona | 1 | 2017 | 23 | 0.040 |
Why?
|
| Molecular Typing | 1 | 2017 | 34 | 0.030 |
Why?
|
| DNA, Satellite | 1 | 2017 | 18 | 0.030 |
Why?
|
| DNA, Intergenic | 1 | 2017 | 17 | 0.030 |
Why?
|
| Feces | 1 | 2020 | 725 | 0.030 |
Why?
|
| HIV-1 | 1 | 2020 | 465 | 0.030 |
Why?
|
| Molecular Epidemiology | 1 | 2017 | 155 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2017 | 103 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2023 | 1151 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2021 | 889 | 0.030 |
Why?
|
| Logistic Models | 1 | 2020 | 1805 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2019 | 1496 | 0.030 |
Why?
|
| Mammals | 1 | 2016 | 256 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 1322 | 0.030 |
Why?
|
| Rural Population | 1 | 2016 | 256 | 0.030 |
Why?
|
| Aging | 1 | 2020 | 1182 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2017 | 971 | 0.020 |
Why?
|
| Brain | 1 | 2022 | 2983 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 4409 | 0.020 |
Why?
|
| Phenotype | 1 | 2019 | 4256 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2017 | 6135 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2018 | 16317 | 0.010 |
Why?
|
| Hospitals, General | 1 | 1975 | 24 | 0.010 |
Why?
|
| Choice Behavior | 1 | 1975 | 132 | 0.010 |
Why?
|
| Decision Making | 1 | 1975 | 655 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 1975 | 1087 | 0.000 |
Why?
|
| Social Welfare | 1 | 1975 | 6 | 0.000 |
Why?
|
| Australia | 1 | 1975 | 139 | 0.000 |
Why?
|
| Transportation of Patients | 1 | 1975 | 59 | 0.000 |
Why?
|
| Family Practice | 1 | 1975 | 91 | 0.000 |
Why?
|
| Employment | 1 | 1975 | 68 | 0.000 |
Why?
|
| Income | 1 | 1975 | 133 | 0.000 |
Why?
|
| Insurance, Health | 1 | 1975 | 138 | 0.000 |
Why?
|
| Motivation | 1 | 1975 | 316 | 0.000 |
Why?
|
| Sex Factors | 1 | 1975 | 1280 | 0.000 |
Why?
|
| Age Factors | 1 | 1975 | 2818 | 0.000 |
Why?
|
| Time Factors | 1 | 1975 | 6293 | 0.000 |
Why?
|